首页> 美国卫生研究院文献>The Journal of Molecular Diagnostics : JMD >Assessing Copy Number Alterations in Targeted Amplicon-Based Next-Generation Sequencing Data
【2h】

Assessing Copy Number Alterations in Targeted Amplicon-Based Next-Generation Sequencing Data

机译:评估靶向的基于扩增子的下一代测序数据中的拷贝数变更

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Changes in gene copy number are important in the setting of precision medicine. Recent studies have established that copy number alterations (CNAs) can be detected in sequencing libraries prepared by hybridization-capture, but there has been comparatively little attention given to CNA assessment in amplicon-based libraries prepared by PCR. In this study, we developed an algorithm for detecting CNAs in amplicon-based sequencing data. CNAs determined from the algorithm mirrored those from a hybridization-capture library. In addition, analysis of 14 pairs of matched normal and breast carcinoma tissues revealed that sequence data pooled from normal samples could be substituted for a matched normal tissue without affecting the detection of clinically relevant CNAs (>|2| copies). Comparison of CNAs identified by array comparative genomic hybridization and amplicon-based libraries across 10 breast carcinoma samples showed an excellent correlation. The CNA algorithm also compared favorably with fluorescence in situ hybridization, with agreement in 33 of 38 assessments across four different genes. Factors that influenced the detection of CNAs included the number of amplicons per gene, the average read depth, and, most important, the proportion of tumor within the sample. Our results show that CNAs can be identified in amplicon-based targeted sequencing data, and that their detection can be optimized by ensuring adequate tumor content and read coverage.
机译:基因拷贝数的变化在精密医学领域很重要。最近的研究已经确定,在通过杂交捕获制备的测序文库中可以检测到拷贝数改变(CNA),但是在通过PCR制备的基于扩增子的文库中对CNA评估的关注相对较少。在这项研究中,我们开发了一种用于检测基于扩增子的测序数据中CNA的算法。根据算法确定的CNA反映了来自杂交捕获库的CNA。此外,对14对匹配的正常和乳腺癌组织的分析显示,从正常样品中收集的序列数据可以替换匹配的正常组织,而不会影响临床相关CNA(> | 2 |拷贝)的检测。通过阵列比较基因组杂交和10个乳腺癌样品中基于扩增子的文库鉴定出的CNA的比较显示出极好的相关性。 CNA算法也与荧光原位杂交相比具有优势,在四个不同基因的38个评估中有33个具有一致性。影响CNA检测的因素包括每个基因的扩增子数量,平均读取深度,最重要的是样品中肿瘤的比例。我们的结果表明,可以在基于扩增子的靶向测序数据中识别CNA,并且可以通过确保足够的肿瘤含量和读取覆盖率来优化其检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号